Genmab
genmab.com
Actively hiring
As featured in
View 1 job
Claim pageClaim
Follow
Overview
Connections
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Hiring now
2
+2 posted in 30 days
Backers
5
RA Capital Management, HongShan
Momentum
42/100
hiring for its size, in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 2026
Formerly Genmab A/S (profoundbio.com)
Sep 29, 2025
Acquisition Genmab Buys Merus For $8bn: A Good Deal If Potential Is Converted Into Revenue · seekingalpha.com
Backed byfrom the funds' portfolios and accelerator catalogs
LAV Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Leapcure leads clinical trials with innovative solutions and a focus on better healthcare. Join us in transforming lives through research.
Transforming enterprise operations through intelligent software.
Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need…
Previous Next keenly FOCUSED Previous Next Dedicated to chains, committed to you. The chain drive division of Schaeffler is now Catensys…
KisoJi Biotechnology. Breakthrough antibody discovery forbreakthrough therapeutics.
Learn more about the tea protocol and how to unlock the rewards for previous and future open-source software contributions.
Overview
Transforming lives with pioneering antibody science. Previous.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Nextech InvestVia a fund
63 portfolio companies: Zymeworks, Vividion Therapeutics (Acquired), Zenith Therapeutics and 60 more
Sofinnova InvestmentsVia a fund
RA Capital ManagementVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Genmab stock reflects higher 2026 revenue guidance
Genmab stock trades at DKK 2,282.00 on September 28, 2026, after a 0.22 percent rise. H1 revenue reached USD 2.051 billion, up 25 percent year over year.
Read more
Report
Genmab stock last trades at DKK 2,282.00 on September 28, 2026
Genmab last traded at DKK 2,282.00 on Nasdaq Copenhagen on September 28, 2026, up 0.22 percent. The company also disclosed new employee equity awards.
Read more
Report
Genmab Grants New Employee Restricted Stock Units and Warrants
Detailed price information for Genmab A/S ADR (GMAB-Q) from The Globe and Mail including charting and trades.
Read more
Report
Wells Fargo Gives a Buy Rating to Genmab (GMAB)
Detailed price information for Genmab A/S ADR (GMAB-Q) from The Globe and Mail including charting and trades.
Read more
Report
From antibody science to patient impact: Genmab's next phase
As the oncology landscape continues to evolve, companies are increasingly evaluated on their ability to translate scientific expertise into sustained
Read more
Report
Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period
Genmab A/S (Nasdaq: GMAB) (
Read more
Report
Why Genmab Stock Was Marching Higher Today
The company's latest asset purchase seems to be impressing analysts.
Read more
Report
Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R2) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)
Genmab A/S (Nasdaq: GMAB) announced today its intention to submit in the first half of 2025 a supplemental Biologics License Application (sBLA) to the U.S. F...
Read more
Report
Tech stack
Technologies named in job postings at Genmab over the last 12 months, by layer, with the share of postings for each.
Technologies in use
6
Postings analysed
2
Stack modernity
69/100AI adopter
Developer tools
LIMS
AI & ML
LLM
Practices & domains
CAPA
Chromatography
GMP
Machine Learning
Sign in to see how your skills match this stack
Sign In
Growth
Hiring Momentum
34/100
Slowing
Open positions
1
0 opened / 0 closed in 30 days
Median time-to-fill
3 days
faster than 92% of the market
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
DevOps
50% ▲
Security
50% ▲
Jobs
Apply